Seeking Alpha
Eli Lilly details NASH effects of weight loss drug (NYSE:LLY)
Eli Lilly (LLY) posts detailed mid-stage results highlighting the benefits of its weight loss drug tirzepatide against a liver disease called NASH. Read more here.
3 days ago